Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 13.

Krayenbuehl, J; Di Martino, M; Guckenberger, M; Andratschke, N (2017). Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial. Radiation Oncology, 12(1):161.

Gkika, E; Tanadini-Lang, S; Kirste, S; Holzner, P A; Neeff, H P; Rischke, H C; Reese, T; Lohaus, F; Duma, M N; Dieckmann, K; Semrau, R; Stockinger, M; Imhoff, D; Kremers, N; Häfner, M F; Andratschke, N; Nestle, U; Grosu, A L; Guckenberger, M; Brunner, T B (2017). Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO). Strahlentherapie und Onkologie, 193(10):823-830.

Klement, R J; Guckenberger, M; Alheid, H; Allgäuer, M; Becker, G; Blanck, O; Boda-Heggemann, J; Brunner, T; Duma, M; Gerum, S; Habermehl, D; Hildebrandt, G; Lewitzki, V; Ostheimer, C; Papachristofilou, A; Petersen, C; Schneider, T; Semrau, R; Wachter, S; Andratschke, N (2017). Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control. Radiotherapy and Oncology, 123(2):227-233.

Tanadini-Lang, S; Rieber, J; Filippi, A R; Fode, M M; Streblow, J; Adebahr, S; Andratschke, N; Blanck, O; Boda-Heggemann, J; Duma, M; Eble, M J; Ernst, I; Flentje, M; Gerum, S; Hass, P; Henkenberens, C; Hildebrandt, G; Imhoff, D; Kahl, H; Klass, N D; Krempien, R; Lohaus, F; Petersen, C; Schrade, E; Wendt, T G; Wittig, A; Høyer, M; Ricardi, U; Sterzing, F; Guckenberger, M (2017). Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease. Radiotherapy and Oncology, 123(2):182-188.

Roesch, J; Panje, C; Sterzing, F; Mantel, F; Nestle, U; Andratschke, N; Guckenberger, M (2016). SBRT for centrally localized NSCLC - What is too central? Radiation Oncology, 11(1):157.

Gulden-Sala, W; Roth, P; Brown, M; Andratschke, N; Weller, M; Stupp, R (2016). Gliome – was ich wissen muss in zehn Fragen. Praxis, 105(6):330-337.

Guckenberger, M; Riesterer, O; Theile, G; Andratschke, N (2015). Herausforderungen und Chancen in der radioonkologischen Behandlung von Patienten im Alter. Schweizer Krebs-Bulletin, 35(3):257-260.

Schanne, D H; Nestle, U; Allgaeuer, M; Andratschke, N; Appold, S; Dieckmann, U; Ernst, I; Ganswindt, U; Grosu, A L; Holy, R; Molls, M; Nevinny-Stickel, M; Semrau, S; Sterzing, F; Wittig, A; Guckenberger, M (2015). Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis. Strahlentherapie und Onkologie, 191(2):125-132.

Guckenberger, M; Riesterer, O; Andratschke, N (2015). Extrakranielle Stereotaxie von Leber- und Pankreas Tumoren. info@onkologie, 1(2015):24-30.

Andratschke, N; Trott, K-R (2015). Hypo-fractionation in Prostate Cancer: Biological Aspects. In: Geinitz, H; Roach III, M; Van As, N. Radiotherapy in Prostate Cancer : Innovative Techniques and Current Controversies. Berlin / Heidelberg: Springer, 155-162.

Klement, R J; Allgaeuer, M; Appold, S; Dieckmann, K; Ernst, I; Ganswindt, U; Holy, R; Nestle, U; Nevinny-Stickel, M; Semrau, S; Sterzing, F; Wittig, A; Andratschke, N; Guckenberger, M (2014). Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics, 88(3):732-738.

Nieder, C; Andratschke, N; Angelo, K; Haukland, E; Grosu, A L (2014). Development of a score predicting survival after palliative reirradiation. Journal of Oncology, 2014:128240.

Guckenberger, M; Andratschke, N (2014). Stereotaktische Bestrahlung - Lokale Tumorkontrolle enorm verbessert. Deutsches Ärzteblatt, 111(45):20-21.

This list was generated on Thu Nov 23 04:33:19 2017 CET.